Buy IGF1-LR3 0.1mg Australia

Description

IGF-1 LR3 0.1mg – Research Grade Peptide IGF-1 LR3 (Insulin-like Growth Factor-1 Long Arg3) is a synthetic analogue of endogenous IGF-1, engineered with an N-terminal 13 amino acid extension and an Arg3 substitution that significantly reduces insulin-like binding protein affinity, resulting in a markedly extended half-life compared to native IGF-1. Each vial contains 1mg of lyophilised IGF-1 LR3, manufactured to research-grade standards for use in licensed laboratory and scientific research only. Key Research Characteristics: Extended half-life (~20–30 hours vs ~12–15 minutes for native IGF-1) due to reduced IGFBP binding Potent agonist at IGF-1R, studied for roles in cellular proliferation, differentiation, and survival signalling Investigated in models of muscle hypertrophy, neuroprotection, and metabolic regulation 83 amino acid analogue; greater systemic activity profile than standard IGF-1 Specifications: Form: Lyophilised powder Storage: Refrigerate at 2–8°C; protect from light For research purposes only. Not for human or veterinary use. Handle in accordance with applicable laboratory safety guidelines.